Previous 10 | Next 10 |
CAMBRIDGE, Mass., June 28, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today announced that it will be added to the Russell 2000®, 3...
The following slide deck was published by TCR2 Therapeutics Inc. in conjunction with this Read more ...
Allogene Therapeutics (NASDAQ: ALLO ) initiated with Neutral rating at Guggenheim. More news on: Allogene Therapeutics, Inc., Fate Therapeutics, Inc., Rubius Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
TCR2 Therapeutics Inc. (TCRR) Q1 2019 Earnings Conference Call May 13, 2019 5:30 PM ET Company Participants Carl Mauch – Director-Investor Relations and Corporate Communications Garry Menzel – Chief Executive Officer Alfonso Quintás – Chief Medical Offic...
TCR2 Therapeutics (NASDAQ: TCRR ): Q1 EPS of -$4.85 may not be comparable to consensus of -$0.53. More news on: TCR2 Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Initiated Phase 1/2 clinical trial for TC-210, TCR 2 ’s lead product candidate targeting mesothelin expressing solid tumors On track to file an IND for TCR 2 ’s lead hematology product candidate, TC-110, in patients with CD19+ non-Hodgkin lymphomas and leukemias in 2H 2019 ...
Preclinical study results published in Nature Communications show superior anti-tumor activity of T cell receptor fusion construct T cells (TRuC™)-T cells compared to chimeric antigen receptor (CAR)-T cells in several mouse models Enhanced in vivo activity of TRuC-T cells over CA...
Earnings to be released after market close on Monday, May 13, 2019 CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (TCR 2 ) (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients sufferi...
Gainers: Quorum Health (NYSE: QHC ) +38% . Speedway Motorsports (NYSE: TRK ) +33% . Entegra Financial (NASDAQ: ENFC ) +25% . Midatech Pharma (NASDAQ: MTP ) +24% . Appliance Recycling Centers of America (NASDAQ: ARCI ) +23% . Nordic American Offshore (NYSE: NAO ) +23% . Synalloy...
The first quarter of 2019 was robust with activity for the biotechnology industry thanks to merger and acquisitions (M&A) in addition to initial public offerings (IPOs). Looking back to the end of last year, the biotech sector took a significant hit in terms of stock performance, ...
News, Short Squeeze, Breakout and More Instantly...
TCR2 Therapeutics Inc. Company Name:
TCRR Stock Symbol:
NASDAQ Market:
TCR2 Therapeutics Inc. Website:
CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR) (TCR 2 or the Company), a clinical-stage cell therapy company with a pipeline of novel next-generation T cell therapies for patients suffering from solid tumors, today announced financial results for...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Radius Global Infrastructure, Inc....
NEW YORK, NY / ACCESSWIRE / March 30, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: U.S. Xpress Enterprises, Inc. (NYSE:...